LM
Therapeutic Areas
Citius Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Mino-Lok® | Catheter-related bloodstream infections (CRBSIs) | Phase 3 |
| LYMPHIR™ (E7777) | Cutaneous T-cell lymphoma (CTCL) | Approved |
| Halo-Lido | Hemorrhoids | Prescription Product |
| CITI-002 | Stem cell therapy | Not specified |
| Anti-infectives in oncology | Oncology-related infections | Not specified |
| Adjunct cancer care | Supportive cancer care | Not specified |